JNJ stock: buy or sell?
February 21st, 2020
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide.
Should I buy JNJ stock?You can't be a successful trader if you don't follow a methodolgy or system that assist you in choosing companies and the correct market timing. That's why is so important to choose your own trading plan that matches with your character as inversor. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.
None of our preferred buy setups matches with Johnson & Johnson stock situation right now, therefore this is not a suitable entry point.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Johnson & Johnson stock a buy?
Financial institutions and banks publish stock ratings everyday.Unfortunately, we couldn't find any rating for JNJ stock for the last 30 days.
JNJ stock analysis
Johnson & Johnson shares stepped up 1.05% to $149.93 on Feb/21.
Shares of Johnson & Johnson closed on February 21st at $149.93 and stepped up a fine 1.05%. Since January 15th when SMA100d and SMA200d crossed up, JNJ price gained $3.41 per share (2.33%). Since last November when JNJ stock price broke up the SMA200d line, it gained $19.87 (15.28%). On Feb/6, JNJ hit new all time highs, pushing higher previous ATH of $154.02 recorded on Feb/5. New ATHs are usual entry points for many trading setups as there aren't higher resistences.
Johnson & Johnson closed this week at $149.93 and stayed stable a tight -0.13%.
Johnson & Johnson stock is trading in the range of its last top and last bottom. Loosing would mean breaking the current uptrend. Breakdowns under last bottom are selling point signals for some trading strategies. Not so far away is the last all-time high Johnson & Johnson marked early February. Early January, SMA20w and SMA40w crossed up triggering a rise of 3.92%. Since mid November 2019 when JNJ stock price broke up the SMA40w line, it gained $17.85 (13.51%).
JNJ stock price history
JNJ IPO was on August 18th, 1980 at $0.01 per share1. Since then, JNJ stock surged a 1,499,200.00%, with an average of 38,441.00% per year. If you had invested right after JNJ's IPO a $1,000 in JNJ stock in 1980, it would worth $14,992,000.00 today.
1: Adjusted price after possible price splits or reverse-splits.
JNJ stock historical price chart
JNJ stock reached all-time highs on Feb 6th with a price of $154.50.
JNJ stock price targetHow much a stock will be priced tomorrow or next week is quite unpredictable However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. You should not follow the analysts' JNJ stock price predictions in the hope that they will be met as they may be wrong and not met. For the last 30 days we have not detected any price prediction for Johnson & Johnson stock by any trusted analyst.
Financials and fundamental analysis
Earnings date and Earnings per ShareSince April, when Johnson & Johnson posted its last earnings report, it . As soon as we get its actual EPS from the earnings report, we will update this review.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsCompared to 2017, last anual turnover report draw a pretty good gain of 6.71% to $81,581.00 million USD. Slightly better, its income margin (compared to sales) rocketed to 18.75%, that is $15,297.00 million. Johnson & Johnson fiscal year ends in December, and to compare its evolution since then, we estimate annual sales and income figures by adding results from the last 4 quarters. This is called TTM (or Twelve Trailing Months). So, Johnson & Johnson TTM sales up to March 2019 were $81,593.00 and income $14,679.00 M dollars. If we compare this TTM figures with the last reported annuality, we can review Johnson & Johnson business evolution since December 2018: Annual sales up to March, compared to lastest yearly report, remained steady a neutral 0.01%. Regarding profit margin, Johnson & Johnson stayed stable -0.76% to 18.75%
|2013||$71,260 M||-||$13,830 M19.4%||-|
|2014||$74,331 M||4.31%||$16,323 M22.0%||18.03%|
|2015||$70,074 M||-5.73%||$15,409 M22.0%||-5.60%|
|2016||$71,890 M||2.59%||$16,540 M23.0%||7.34%|
|2017||$76,450 M||6.34%||$1,300 M1.7%||-92.14%|
|2018||$81,581 M||6.71%||$15,297 M18.8%||1,076.69%|
|TTM||$81,593 M||0.01%||$14,679 M18.0%||-4.04%|
Quarterly financial resultsJohnson & Johnson posted $20,021.00 M in sales for 2019-Q1, a -1.83% less compared to previous quarter. Reported quarter income marked $3,749.00 million with a profit margin of 18.73%. Profit margin gained a 3.81% compared to previous quarter when profit margin was 14.92%. When comparing sales to same quarter last year, Johnson & Johnson sales marked a tight movement and stayed stable a 0.06%.
|2017-Q2||$18,850 M||-||$3,830 M20.3%||-|
|2017-Q3||$19,650 M||4.24%||$3,760 M19.1%||-1.83%|
|2017-Q4||$20,195 M||2.77%||$-10,713 M-53.0%||-384.92%|
|2018-Q1||$20,009 M||-0.92%||$4,367 M21.8%||-140.76%|
|2018-Q2||$20,830 M||4.10%||$3,954 M19.0%||-9.46%|
|2018-Q3||$20,348 M||-2.31%||$3,934 M19.3%||-0.51%|
|2018-Q4||$20,394 M||0.23%||$3,042 M14.9%||-22.67%|
|2019-Q1||$20,021 M||-1.83%||$3,749 M18.7%||23.24%|
Johnson & Johnson ownershipWhen you are planning to invest in shares of a stock, it's always worth to review its ownership structure.
Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Johnson & Johnson, 0.08% of all outstanding shares are owned by its staff.
In case of Johnson & Johnson stock, 70.81% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for JNJ stock account 0.00%, no big difference from last month.
For a better understanding, the next table shows ownership data compared to other related companies:
|Market cap||$394.3 B|
|Total shares||2,630.0 M|
|Float shares||2,630.0 M|
|- Institutional holdings (%)||70.8%|
|- Insider holdings (%)||0.1%|
|Shares in short selling||0.0%|
|Friday, February 21st, 2020|
|Day range||$147.54 - $150.24|
|Average true range||$1.71|
|50d mov avg||$147.30|
|100d mov avg||$139.80|
|200d mov avg||$136.12|
Johnson & Johnson performanceStocks performance is always measured in comparision to the market or competitors and related stocks in the same industry. We picked as the bechmarking frame for Johnson & Johnson stock.
Johnson & Johnson competitorsUnfortunately, we could not find any public company that could be defined as Johnson & Johnson competitor. This doesn't mean Johnson & Johnson does not have any competitor in the market, it's just we could not detected it.
Latest JNJ stock news
- InvestorPlaceWhy Johnson & Johnson Stock Isn’t a Buy… YetJuly 29, 2019
- Seeking AlphaJohnson & Johnson's Stock May Be Too Cheap In A Low Interest Rate WorldJuly 24, 2019
- InvestorPlaceIs Johnson & Johnson Stock Losing Its Shine?July 24, 2019
- InvestorPlaceJohnson & Johnson Could Turn Around After its Strong EarningsJuly 24, 2019
- InvestorPlaceJohnson & Johnson Earnings: JNJ Stock Dips Despite Q2 Beat, Raised GuidanceJuly 16, 2019